FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, namely immunology and may be used for immune system stimulation. That is ensured by administering a composition containing a complex of isolated carbonic anhydrase IX (CA9) protein and an antigen, wherein the isolated CA9 proteins and the antigen are noncovalently linked to each other, into an individual. The group of inventions also refers to a composition containing a purified population of dendrite cells coming into contact with the above composition.
EFFECT: group of inventions provides immune cell stimulation by enhancing the antigen immunogenicity ensured by adding the complex with the CA9 protein which can function as a chaperone protein.
18 cl, 6 dwg, 8 ex
Title | Year | Author | Number |
---|---|---|---|
AGENTS AND METHODS BASED ON USING FIBRONECTIN OF DOMAIN EDA | 2006 |
|
RU2430738C2 |
COATED ONCOLYTIC ADENOVIRUS FOR ANTICANCER VACCINES | 2015 |
|
RU2695375C2 |
IMMUNOSTIMULATING COMPOSITIONS | 2016 |
|
RU2732118C2 |
RECOMBINANT ADENOVIRUS CONTAINING TRANS-SPLICING MEDIATING RIBOZYME, AND ANTI-CANCER THERAPEUTIC GENE, AND USING IT | 2012 |
|
RU2575620C2 |
VACCINE COMPOSITIONS AND METHODS OF USE THEREOF | 2010 |
|
RU2600798C2 |
DELIVERY OF BIOMOLECULES INTO CELLS OF IMMUNE SYSTEM | 2015 |
|
RU2739794C2 |
ONCOLYTIC ADENOVIRUSES ENCODING BISPECIFIC ANTIBODIES, AS WELL AS METHODS AND APPLICATIONS ASSOCIATED THEREWITH | 2016 |
|
RU2725799C2 |
COMBINATION OF AN IMMUNE CHECKPOINT MODULATOR AND A COMPLEX CONTAINING A CELL-PENETRATING PEPTIDE, A CARGO MOLECULE, AND A TLR PEPTIDE AGONIST, FOR APPLICATION IN MEDICINE | 2017 |
|
RU2769314C1 |
VECTOR, CO-EXPRESSING MOLECULES FOR VACCINATION AND COSTIMULATORY MOLECULES | 2016 |
|
RU2714157C2 |
COMBINATION OF IMMUNE CHECKPOINT MODULATOR AND COMPLEX CONTAINING CELL-PENETRATING PEPTIDE, CARGO MOLECULE, AND TLR PEPTIDE AGONIST FOR MEDICAL USE | 2017 |
|
RU2748378C2 |
Authors
Dates
2013-11-10—Published
2008-11-03—Filed